Clinical review 125: The insulin receptor and its cellular targets

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 3, 2001, Pages 972-979

  Kido, Yoshiaki ^a   Nakae, Jun ^a   Accili, Domenico ^a,b  

^a The New York Presbyterian Hospital   (United States)

^b Berrie Research Pavilion   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR; LIPID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; PROTEIN SERINE THREONINE KINASE; TYROSINE KINASE RECEPTOR;

ENZYME REGULATION; GENE EXPRESSION; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; INSULIN RESISTANCE; LIPOGENESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTO ONCOGENE; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CAENORHABDITIS ELEGANS; DNA-BINDING PROTEINS; FORKHEAD TRANSCRIPTION FACTORS; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; PHOSPHOPROTEINS; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 0035044213     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.3.972     Document Type: Review

References (113)

1. Action of insulin on the permeability of cells to free hexoses, as studied by its effect on the distribution of galactose
2. 125I-insulin to the plasma membrane and its relation to insulin bioactivity
3. Deconstructing type 2 diabetes
4. Targeted gene mutations define the roles of insulin and IGF-I receptors in mouse embryonic development
5. Mutational analysis of insulin receptor function: Consensus and controversy
6. Syndromes associated with insulin resistance and acanthosis nigricans
7. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene
8. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles
9. Tissue-specific insulin resistance in mice with combined mutations of Insulin Receptor, IRS-1 and IRS-2
10. Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes
11. Liver-specific insulin receptor knockout mice are severely insulin resistant
12. Crystal structure of the tyrosine kinase domain of the human insulin receptor
13. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog
14. Site-site interactions among insulin receptors. Characterization of the negative cooperativity
15. Mechanism of insulin and IGF-I receptor activation and signal transduction specificity. Receptor dimer cross-linking, bell-shaped curves, and sustained versus transient signaling
16. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds
17. Genetics of mouse growth
18. Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development
19. Role of insulin-like growth factors in embryonic and postnatal growth
20. Insulin receptor isoform A, a newly recognized, high-affinity insulin- like growth factor II receptor in fetal and cancer cells
21. Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells
22. The IRS-signalling system: A network of docking proteins that mediate insulin and interleukin signalling
23. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
24. Role of IRS-2 in insulin and cytokine signalling
25. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family
26. A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family
27. A Grb2-associated docking protein in EGF- and insulin-receptor signalling
28. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1
29. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene
30. Disruption of IRS-2 causes type 2 diabetes in mice
31. Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians
32. Exclusion of insulin receptor substrate 2 (IRS-2) as a major locus for early-onset autosomal dominant type 2 diabetes
33. Search for variants of the gene-promoter and the potential phosphotyrosine encoding sequence of the insulin receptor substrate-2 gene: Evaluation of their relation with alterations in insulin secretion and insulin sensitivity
34. Insulin receptor substrate 3 is not essential for growth or glucose homeostasis
35. Mice lacking insulin receptor substrate 4 exhibit mild defects in growth, reproduction, and glucose homeostasis
36. Role of Gab1 in heart, placenta, and skin development and growth factor- and cytokine-induced extracellular signal-regulated kinase mitogen-activated protein kinase activation
37. Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes
38. Irs-2 coordinates Igf-1 receptor-mediated β-cell development and peripheral insulin signalling
39. Altered function of insulin receptor substrate-1-deficient mouse islets and cultured β-cell lines
40. Exocytosis of insulin promotes insulin gene transcription via the insulin receptor/PI-3 kinase/p70 s6 kinase and CaM kinase pathways
41. The role of PI 3-kinase in insulin action
42. Bifurcation of lipid and protein kinase signals of PI3Kγ to the protein kinases PKB and MAPK
43. Effects of wortmannin on increased glucose transport by insulin and norepinephrine in primary, culture of brown adipocytes
44. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin
45. Ras-independent and wortmannin-sensitive activation of glycogen synthase by insulin in Chinese hamster ovary, cells
46. Insulin stimulation of glycogen synthesis and glycogen synthase activity is blocked by wortmannin and rapamycin in 3T3-L1 adipocytes: Evidence for the involvement of phosphoinositide 3-kinase and p70 ribosomal protein-S6 kinase
47. Phosphatidylinositol 3-kinase signals activation of p70 S6 kinase in situ through site-specific p70 phosphorylation
48. Control of PHAS-I phosphorylation in 3T3-L1 adipocytes: Effects of inhibiting protein phosphatases and the p7056k-signaling pathway
49. Protein kinase B/Akt mediates effects of insulin on hepatic insulin-like growth factor-binding protein-1 gene expression through a conserved insulin response sequence
50. Phosphatidylinositol 3-kinase, but not p70/p85 ribosomal S6 protein kinase, is required for the regulation of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by insulin. Dissociation of signaling pathways for insulin and phorbol ester regulation of PEPCK gene expression
51. The inability of phosphatidylinositol 3-kinase activation to stimulate GLUT4 translocation indicates additional signaling pathways are required for insulin-stimulated glucose uptake
52. Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 α subunit of phosphoinositide 3-kinase
53. 3-Phosphoinositide-dependent protein kinase-1 (PDK1): Structural and functional homology with the Drosophila DSTPK61 kinase
54. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region
55. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB
56. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1
57. Partial purification and characterization of a wortmannin-sensitive and insulin-stimulated protein kinase that activates heart 6-phosphofructo-2-kinase
58. The PI3K-PDK1 connection: More than just a road to PKB
59. Akt activation by growth factors is a multiple-step process: The role of the PH domain
60. Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation
61. Role of translocation in the activation and function of protein kinase B
62. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation
63. A role for protein kinase Bbeta/Akt2 in insulin-stimulated GLUT4 translocation in adipocytes
64. Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis
65. Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport
66. Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt
67. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
68. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction
69. Cellular survival: A play in three Akts
70. Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway
71. 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro
72. Protein kinase C-ζ as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport
73. Requirement of atypical protein kinase clambda for insulin stimulation of glucose uptake but not for akt activation in 3T3-L1 adipocytes
74. Requirement of protein kinase Cζ for stimulation of protein
75. Elegans biology
76. Aging, life span, and senescence
77. daf-2, daf-16 and daf-23: Genetically interacting genes controlling Dauer formation in Caenorhabditis elegans
78. Cell nonautonomy of C. elegans daf-2 function in the regulation of diapause and life span
79. An insulin-like signaling pathway affects both longevity and reproduction in Caenorhabditis elegans
80. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans
81. The DAF-3 Smad protein antagonizes TGF-beta-related receptor signaling in the Caenorhabditis elegans dauer pathway
82. The forkhead transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans
83. The C. elegans PTEN homolog, DAF-18, acts in the insulin receptor-like metabolic signaling pathway
84. Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor
85. The homeotic gene forkhead encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo
86. Hepatocyte nuclear factor 3/forkhead or "winged helix" proteins: A family of transcription factors of diverse biologic function
87. Fusion of a forkhead domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma
88. Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily
89. Hepatocyte nuclear factor-3 (HNF-3) binds to the insulin response sequence in the IGF binding protein-1 (IGFBP-1) promoter and enhances promoter function
90. Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a wortmannin-sensitive pathway
91. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1
92. Differential regulation of gene expression by insulin and IGF-I receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR
93. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor
94. Regulation of the forkhead transcription factor FKHR, but not the PAX3- FKHR fusion protein, by the serine/threonine kinase Akt
95. Negative regulation of the forkhead transcription factor FKHR by Akt
96. Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B
97. Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence
98. Direct control of the forkhead transcription factor AFX by protein kinase B
99. AFX-like forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
100. Forkhead transcription factors: New insights into protein kinase B (c- akt) signaling
101. Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site
102. Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane
103. Molecular basis of insulin-stimulated GLUT4 vesicle trafficking. Location! Location! Location!
104. Synip: A novel insulin-regulated syntaxin 4-binding protein mediating GLUT4 translocation in adipocytes
105. Regulation of insulin-stimulated GLUT4 translocation by Munc18c in 3T3L1 adipocytes
106. Insulin stimulates tyrosine phosphorylation of the proto-oncogene product of c-Cbl in 3T3-L1 adipocytes
107. A novel, multifuntional c-Cbl binding protein in insulin receptor
108. Signaling pathways in insulin action: Molecular targets of insulin resistance
109. Regulation of the insulin signalling pathway by cellular protein-tyrosine phosphatases
110. Transgenic mice deficient in the LAR protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis
111. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene
112. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice